Health Care Equipment & Services

USBC Inc. faces financial turbulence but its cutting‑edge non‑invasive glucose monitors offer a bright future in a growing health tech market.

Utah Medical Products: Nasdaq‑listed medical device firm driving innovation in women’s & pediatric care with solid growth, $208 M market cap and strong P/E of 18.4.

MedMira Inc., a TSX‑listed biotech firm, advances rapid diagnostics and medical equipment, offering promising growth amid market volatility and strategic partnerships.

MDCE’s new strategy mixes flash auctions for $100k‑$200k cash with an AI vision platform spanning manufacturing, healthcare and more—offering quick cash and future tech revenue.

USBC Inc. leads the non‑invasive glucose‑monitoring market, using radio‑microwave spectroscopy to boost patient outcomes. Despite current losses, its innovative tech positions it for future growth.

Explore SMAIO SA’s 2026 market journey: from record lows to recovery, a €49M cap, negative P/E yet driven by R&D innovation on NYSE Euronext Paris.

Hims & Hers stock surges 10% ahead of May 11 earnings, analysts expect $0.03 EPS and a post‑earnings range of $22–$30, driving growth in telehealth & pharma partnerships.

Medtronic PLC’s latest moves: neurology implants, AI health‑tech partnerships, and a $35 M drug push, amid data‑breach scrutiny and cautious investor sentiment. Explore how these shifts shape the company’s value and risk profile.

DaVita’s Q1 2026 results beat earnings expectations, with $3.416B revenue and $198M net income, boosting its clinical‑care leadership and investor confidence.

Health Canada clears ZenGUARD™ filters for sale, letting Zentek Ltd. boost commercial air‑filter sales and grow its nano‑material portfolio.